Abstract
The Funding statement had an error in the reference of one project. Instead of PTDC/EMD-TLM/4644/2021, it should be PTDC/EMD-TLM/7289/2020. This work was supported by UID/BIM/50005/2019 and PTDC/EMD-TLM/7289/2020, a project funded by Fundação para a Ciência e a Tecnologia - Ministério da Ciência, Tecnologia e Ensino Superior (FCT-MCTES), through Fundos do Orçamento de Estado (Portugal). CSL also acknowledges FCT-MCTES fellowship PD/BD/135045/2017. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
| Original language | English |
|---|---|
| Article number | 800151 |
| Journal | Frontiers in Cardiovascular Medicine |
| Volume | 8 |
| DOIs |
|
| Publication status | Published - 2021 |
| Externally published | Yes |
Keywords
- amyotrophic lateral sclerosis
- gamma′ fibrinogen
- prognosis
- respiratory function
- survival
Fingerprint
Dive into the research topics of 'Corrigendum: γ′ Fibrinogen as a Predictor of Survival in Amyotrophic Lateral Sclerosis (Frontiers in Cardiovascular Medicine, (2021), 8, (715842), 10.3389/fcvm.2021.715842)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver